Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia.

MLA

Petgrave, Yonique, et al. “Acute Kidney Injury Following Treatment with CD19-Specific CAR T-Cell Therapy in Children, Adolescent, and Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia.” Pediatric Nephrology (Berlin, Germany), vol. 39, no. 8, Aug. 2024, pp. 2495–503. EBSCOhost, https://doi.org/10.1007/s00467-024-06331-7.

APA

Petgrave, Y., Selukar, S., Epperly, R., Naik, S., Santos, N. D., Triplett, B. M., Gottschalk, S., Bissler, J., & Talleur, A. C. (2024). Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia. Pediatric Nephrology (Berlin, Germany), 39(8), 2495–2503. https://doi.org/10.1007/s00467-024-06331-7

Chicago

Petgrave, Yonique, Subodh Selukar, Rebecca Epperly, Swati Naik, Noel DeLos Santos, Brandon M Triplett, Stephen Gottschalk, John Bissler, and Aimee C Talleur. 2024. “Acute Kidney Injury Following Treatment with CD19-Specific CAR T-Cell Therapy in Children, Adolescent, and Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia.” Pediatric Nephrology (Berlin, Germany) 39 (8): 2495–2503. doi:10.1007/s00467-024-06331-7.